1. Home
  2. Labeler Index
  3. Csl Plasma Inc.
  4. 81839-782
  5. NDC Package Code: 81839-782-02 Anticoagulant Sodium Citrate

NDC Package 81839-782-02 Anticoagulant Sodium Citrate

Trisodium Citrate Dihydrate Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
81839-782-02
Package Description:
30 BAG in 1 CARTON / 250 mL in 1 BAG (81839-782-01)
Product Code:
81839-782
Proprietary Name:
Anticoagulant Sodium Citrate
Non-Proprietary Name:
Trisodium Citrate Dihydrate
Substance Name:
Trisodium Citrate Dihydrate
Usage Information:
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [See Dosage and Administration (2).]
11-Digit NDC Billing Format:
81839078202
Product Type:
Human Prescription Drug
Labeler Name:
Csl Plasma Inc.
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • TRISODIUM CITRATE DIHYDRATE 40 mg/mL
    • Pharmacologic Class(es):
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    BA125750
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    07-01-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 81839-782-02?

    The NDC Packaged Code 81839-782-02 is assigned to a package of 30 bag in 1 carton / 250 ml in 1 bag (81839-782-01) of Anticoagulant Sodium Citrate, a human prescription drug labeled by Csl Plasma Inc.. The product's dosage form is solution and is administered via intravenous form.

    Is NDC 81839-782 included in the NDC Directory?

    Yes, Anticoagulant Sodium Citrate with product code 81839-782 is active and included in the NDC Directory. The product was first marketed by Csl Plasma Inc. on July 01, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 81839-782-02?

    The 11-digit format is 81839078202. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-281839-782-025-4-281839-0782-02